By the editorial team · · Disclosed sponsored placement
The link above is a contextual, do-follow editorial link placed inside a real article on a publication we own and operate.
Link Building
Supplement backlinks run $300 to $2,000 per link in 2026. What drives the premium, what vendors really charge, and what a paid placement can legally say.
By the BacklinkPlace editorial team · Last updated August 2026 · 8 min read
Try it · Placement Studio
Pick a niche and see the owned portals we would match you with, with Domain Rating and live organic traffic on every card.
Pick a niche and tap Match portals to see the owned publications in our network that fit your target.
owned portals matched · open one to preview the placement
Supplement backlinks price inside the restricted band: budget $300 to $2,000 per quality link, against $100 to $500 for a medium-competition niche. Health and YMYL vendors that will quote at all commonly ask $400 to $600, roughly a 20 to 50 percent premium over baseline. The reason is not extra work. Writing a supplement article costs the same as writing a SaaS one. You are paying for a publisher who will accept the category, and a large share of them will not.
We own and operate our own publisher network, so we compete with several of the vendors named below. Read the comparison with that in mind. It is also why every figure here carries a source and a date.
Plan on $300 to $2,000 per link. That is the published 2026 band for restricted verticals, which groups supplements and nutraceuticals with finance, gambling and healthcare. Medium-competition niches such as education, IT and ecommerce run $100 to $500, and low-competition niches $50 to $200. The broad market average buyers report being willing to pay across all niches is around $508.95, up roughly 45 percent since 2022, with the median editorial link on a DA 30 to 50 site landing at $350 to $500.
| Segment | Published 2026 figure | Source | What the number measures |
|---|---|---|---|
| Low-competition niches | $50 to $200 | 2026 link pricing surveys | Ordinary supply. Price tracks host authority and nothing else |
| Medium competition | $100 to $500 | 2026 link pricing surveys | The baseline the supplement premium is measured against |
| Restricted band: supplements, finance, gambling, healthcare | $300 to $2,000 | 2026 link pricing surveys | Scarcity of willing publishers, not extra work |
| Healthcare and YMYL vendor quotes | $400 to $600 per link, a 20 to 50 percent premium | 2026 vendor rate cards | What vendors that accept health work actually charge |
| Guest post, market average | $459 average (Adsy); $295 direct or $461 through a vendor (BuzzStream) | Adsy February 2026, BuzzStream August 2026 | All niches. The vendor margin is visible in the gap between $295 and $461 |
| Link insertion, market average | $225 average (Adsy), $179 average (BuzzStream) | Adsy February 2026, BuzzStream August 2026 | Insertions across all niches, so supplements sit above both figures |
| Guest post by authority band | DR 1 to 30 $332, DR 31 to 70 $555, DR 71+ $2,025 | Adsy February 2026, 52,671 sites | Where the restricted-band ceiling comes from |
Treat the averages carefully. Two widely cited benchmarks for a paid link insertion disagree by more than double, with Ahrefs at $361.44 and a competing survey near $141. Adsy, surveying 52,671 sites in February 2026, found the likely reconciliation: listed prices run roughly four times what deals actually close at. Anyone quoting you a single market average without saying which of those numbers they mean is not being precise. Our own rates sit on pricing, and the vertical-by-vertical breakdown is on niche edit pricing.
Because the category is screened out before pricing is discussed. Loganix, a well-known US vendor, publishes a restricted list of "no pharma, adult, casino/gambling, etc. links" and says it screens out "poker, pills, adult sites" during vetting. We re-checked that wording at source on 31 August 2026. Its published rates are $200 for a multi-topic edit and $400 for a niche edit, with delivery usually around three weeks, and none of that applies if the topic is excluded up front.
That refusal is a policy decision, not a quality judgment about your brand. Publishers weigh the reputational and legal exposure of hosting health claims against the few hundred dollars a placement earns them, and a large share decide it is not worth it. The same dynamic sets prices in casino link building and cannabis link building, where the premium is likewise permission rather than production.
Loganix also publishes the strictest host standards we have found in the market, which is worth knowing whoever you buy from: 1,000 or more monthly organic visits, DR or DA of 30 plus, 100 or more indexed pages, 50 or more referring domains, and traffic trending upward. Those are reasonable screens. Apply them yourself before you pay anyone.
Yes, in one specific way that changes what your placement can say. Google treats dietary supplements as a restricted advertising category rather than a prohibited one, so paid search stays open to supplement brands once ads clear policy. That is a genuinely different position from addiction treatment, where Google and Meta have required LegitScript certification since 2018 and the paid channel is gated before it is expensive. If you sell treatment services rather than products, addiction treatment link building covers that case.
What Google does block under its unapproved substances policy is narrower and more consequential than most brands expect: supplements containing active pharmaceutical or dangerous ingredients, products containing hCG marketed for weight loss, anything implying it is as effective as a prescription drug, and non-approved products marketed as safe or effective for preventing or curing disease. Google points to LegitScript for verification. The practical result is that the products with the strongest margins are often the ones whose claims are hardest to advertise, which pushes budget toward organic and toward the kind of editorial placement this article is about.
It can describe ingredients, mechanisms, formulation and category context. It cannot assert a health outcome the evidence does not support. The Federal Trade Commission issued its Health Products Compliance Guidance on 20 December 2022, its first update in nearly 25 years, and it requires competent and reliable scientific evidence for health claims, generally randomized controlled human clinical testing conducted by qualified experts. Animal and in vitro studies alone are not sufficient to substantiate a health representation.
This matters for link buying specifically, because a sponsored article is advertising and the claims in it are the advertiser's. On 13 April 2023 the FTC sent a Notice of Penalty Offenses to roughly 670 companies marketing OTC drugs, homeopathic products, dietary supplements and functional foods. Receiving the notice is not a finding of wrongdoing. What it does is establish knowledge, which exposes the recipient to civil penalties of up to $50,120 per violation at the time of the notice for conduct the FTC has already found unlawful. The notice also names two failures that are easy to commit in a paid article without noticing: misrepresenting the level or type of substantiation behind a claim, and stating that a claim is scientifically or clinically proven when it is not.
| Claim in a sponsored article | Where it usually sits | What it needs |
|---|---|---|
| "Contains 500mg of magnesium glycinate per serving" | Safe | Accurate label data. A factual composition statement, not a health claim |
| "Magnesium is involved in muscle and nerve function" | Generally safe | A structure or function description supported by established nutrition science, kept general |
| "Clinically proven to improve sleep quality" | High risk | Named as unlawful if the substantiation does not exist. "Clinically proven" is a specific FTC trigger phrase, not a stylistic flourish |
| "Reduces inflammation" or "lowers blood pressure" | High risk | Competent and reliable scientific evidence, generally randomized controlled human clinical testing. A cell study does not carry it |
| "Helps prevent cognitive decline" | Highest risk | A disease prevention claim. Also blocked by Google Ads policy for non-approved products |
None of this is legal advice and your counsel should review claim language before it runs. Operationally, brands running placements across several publishers usually end up needing a way to track the obligations and control language attached to each claim rather than re-litigating it article by article. The practical rule for link buying is simpler than the regulation: write ingredient-led, not outcome-led.
Count referring domains to the specific page you want to rank, not to your whole domain, then compare against the pages already on page one for that term. Published data puts the median page-one result at 907 referring domains across industries, with a range from 76 in apparel to 3,027 in finance and insurance. Health sits between those poles, well above apparel and below finance. Anyone quoting you a flat number without asking which page and which query is guessing.
Two other benchmarks are worth planning against. Healthcare sites are reported to need a Domain Authority around 43 to 55 to compete at all, with the top decile of YMYL competitors at DA 75 and above. And BuzzStream found in August 2026 that only 1.37 percent of a 500,000-site database cleared DR or DA 65 combined with 10,000 monthly visits. That is the entire supply of genuinely strong hosts across every niche at once, before anyone has been asked whether they accept supplement content. Scarcity is not a sales line here, it is arithmetic.
Niche edits are cheaper and faster, guest posts give you more control over context, and for supplements the choice usually turns on what the article needs to say. A link inserted into an existing indexed piece inherits that article's age and any authority it has already accumulated, which is why insertions average $225 against $459 for a guest post in the Adsy data. But you are inserting into someone else's copy, so you cannot shape the surrounding claims.
A sponsored article gives you the whole page, which in a regulated category is worth more than it sounds. You control the hedging, the disclosure and the angle, and you can build the piece around an ingredient or a research question rather than a product. If you are weighing the two formats generally, guest posts versus niche edits covers the mechanics, and supplement link building shows how both work on our own network.
Split your targets deliberately. Product and category pages carry the commercial terms and need the authority, but they are the hardest placements to buy, because a publisher reads a product link as pure advertising and prices or refuses it accordingly. Ingredient explainers, research summaries and comparison pages accept links far more easily, cost less, and can pass authority internally to the product pages behind them. They also age better: an ingredient page is still accurate after a SKU is discontinued.
Beyond bought placements, the assets that earn supplement links without asking are third-party testing results, original consumer or formulation data, and genuinely useful reference content. That is slower, and it is the honest answer to why link budgets exist at all. Cold outreach data from 2026 puts reply rates at 8.5 percent and an average of 146 emails sent per link actually earned, which is roughly a week of one person's time for a single link before anyone in this category has said no on policy grounds.
The rest is screening, and it is the same discipline whoever you buy from. Check live organic traffic and not only Domain Rating, because DR is a purchasable number. Check the inbound to outbound link ratio: worse than about 4 to 1 usually marks a site whose real business is selling links. Read the existing archive and ask whether a health article belongs there. Our full quality screen is on quality, the wider medical vertical is covered on health link building, and if you are buying across several verticals at once, niche edits by industry maps the whole network.
BacklinkPlace · Get started
A managed link building service on a first-party publisher network. Browse owned portals by niche, Domain Rating, and live traffic, then we write, publish, and report the live, contextual do-follow link. White-hat, disclosed, no PBNs.
Keep reading
Nine niche edit vendors with verified July 2026 rates, what the market actually charges by Domain Rating, and the three checks that separate a real placement from recycled link inventory.
July 2026 · 9 min read
Link BuildingTen vendors compared on published 2026 rate cards, and the structural question that actually decides which one fits: does it own the health publications it places on, or does it have to ask? Healthcare-focused vendors quote $400 to $600 per link. Here is what that premium buys, and what it does not.
August 2026 · 9 min read
PricingHow much do backlinks cost in 2026? An honest breakdown of guest post and backlink pricing by Domain Rating, traffic, and niche, and why the cheapest links are the riskiest.
June 2026 · 9 min read
Place your first link
Browse the owned network, pick your portals, and we write, publish, and report the live link. Owned portals, do-follow, disclosed, cancel anytime.